Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal epinephrine powder versus intramuscular EpiPen pharmacokinetic study in adults with seasonal allergic rhinitis
MOH_2020-05-27_008957Phase 2Completed
- Sponsor
- Nasus Pharma
- Start
- Mar 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of epinephrine in anaphylaxis (5 arms), sponsored by Nasus Pharma. Primary endpoints: Blood epinephrine concentrations, Pharmacokinetics under normal nasal conditions and 1 more. Started Mar 2020; status: completed.
02
Drugs
epinephrine
03
Conditions
anaphylaxis
Beyond the preview
Go deeper on MOH_2020-05-27_008957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-05-27_008957.